Tekmira Pharmaceuticals Corporation, an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV), announced today that TKM-Ebola-Guinea...

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, provides an update on its Ebola program. The Company is reporting it has commenced limited GMP manufacture...

He arrived at the Nebraska Medical Center on September 5 after contracting Ebola Virus Disease (EVD) while treating patients in Sierra Leone. Today he was released after the CDC confirmed that two separate...

Just one day after the announcement that the US Food and Drug Administration (FDA) and Health Canada authorized Tekmira Pharmaceuticals to provide TKM-Ebola for treatment under expanded access protocols...

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today announced that the FDA has authorized Tekmira to provide TKM-Ebola for treatment under expanded access...

The Food and Drug Administration (FDA) has verbally confirmed they have modified the full clinical hold placed on Tekmira Pharmaceutical’s TKM-Ebola Investigational New Drug Application (IND) to...